An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity

Yuanming Xu, Lucia Campos Carrascosa, Yik Andy Yeung, Matthew Ling-Hon Chu, Wenjing Yang, Ivana Djuretic, Danielle C Pappas, John Zeytounian, Zhouhong Ge, Valeska de Ruiter, Gabriel R Starbeck-Miller, James Patterson, Diamanda Rigas, Shih-Hsun Chen, Eugenia Kraynov, Patrick P Boor, Lisanne Noordam, Michael Doukas, Dave Tsao, Jan N IjzermansJie Guo, Dirk J Grünhagen, Joris Erdmann, Joanne Verheij, Martin E van Royen, Pascal G Doornebosch, Renny Feldman, Terrence Park, Salah Mahmoudi, Magdalena Dorywalska, Irene Ni, Sherman M Chin, Tina Mistry, Lidia Mosyak, Laura Lin, Keith A Ching, Kevin C Lindquist, Changhua Ji, Luz Marina Londono, Bing Kuang, Robert Rickert, Jaap Kwekkeboom, Dave Sprengers*, Tzu-Hsuan Huang*, Javier Chaparro-Riggers*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

36 Citations (Scopus)

Fingerprint

Dive into the research topics of 'An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity'. Together they form a unique fingerprint.

Immunology and Microbiology